1. Home
  2. SGHT vs PCYO Comparison

SGHT vs PCYO Comparison

Compare SGHT & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$8.51

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Logo Pure Cycle Corporation

PCYO

Pure Cycle Corporation

HOLD

Current Price

$11.46

Market Cap

249.5M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
PCYO
Founded
2011
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Water Supply
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
309.6M
249.5M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
SGHT
PCYO
Price
$8.51
$11.46
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$9.08
N/A
AVG Volume (30 Days)
263.8K
79.8K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
12.50
EPS
N/A
0.36
Revenue
$77,363,000.00
$1,227,787.00
Revenue This Year
$11.67
N/A
Revenue Next Year
$10.39
N/A
P/E Ratio
N/A
$31.75
Revenue Growth
N/A
171.54
52 Week Low
$3.19
$9.71
52 Week High
$9.24
$12.44

Technical Indicators

Market Signals
Indicator
SGHT
PCYO
Relative Strength Index (RSI) 73.02 56.78
Support Level $8.00 $10.51
Resistance Level $8.80 $11.65
Average True Range (ATR) 0.37 0.30
MACD -0.04 0.01
Stochastic Oscillator 59.84 48.95

Price Performance

Historical Comparison
SGHT
PCYO

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: